In Conversation

"Our mission is to improve patient healthcare by bringing high quality and validated genomic knowledge into everyday clinical practice."

"Historically, clinical research has maintained a particularly high quality in Portugal. Moreover, in the last ten years, despite the economic restraints and the squeeze we have…

"In Portugal, we have effectively changed the way that companies evaluate and assess the market, both regarding performance, competitiveness and in evaluation of commercial areas effectiveness."

"Despite the size of the market in Portugal, the affiliate has to make the right decisions to keep our financial key performance indicators healthy."

"There is vast potential in healthcare, and the data is so massive—far more significant than banking or telecommunications— that we need help in harnessing the potential…

"Teva is recognized by the Portuguese government as an ideal partner in this area, as we offer the right balance between accessibility and innovation. Therefore, we…

". Inevitably, we had to make some concessions in our policy here, but Takeda’s global strategy is to implement a responsible pricing plan because we want…

"Between 2016 and 2017 Portugal approved more than 120 innovative drugs in areas including oncology, HIV, and rare diseases"

"Five years ago, we employed 50 people, today we have almost 200 employees working for Mylan."

"At Quilaban’s core is a desire to develop global solutions for our customers, as opposed to selling products or equipment"

"Portugal is unique in Europe as it has electronic health records designed by the government in primary care and hospitals"

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here